The language used by doctors contributes to why patients don't understand what they are told; the number of American adults without health insurance grew 1.3 percentage points from the end of 2016 to the end of 2017; women are increasingly faced with the decision between 2D and 3D mammograms.
There are a number of reasons why patients have trouble understanding what the doctor tells them, but one of the biggest culprits is the language used. According to The Washington Post, while patient education, health literacy, and cultural differences all factor in, the bigger problem is that the language of medicine can obscure the plain meaning of words. Doctors tend to use layers of equivocation, which can hamper communication with patients. The result? Patients return home from an appointment and cannot explain to a loved one what the doctor said.
From the end of 2016 to the end of 2017, the number of American adults without health insurance grew from 10.9% to 12.2%. The 1.3-percentage-point increase may be modest, but it represents the first increase since 2008, according to Los Angeles Times. The populations for whom the decline in coverage was largest were young adults, blacks, Latinos, and households with incomes less than $36,000 a year. It is not clear whether media coverage of repeal and replace efforts contributed to the decline in coverage as people questioned whether the government would enforce the penalty for not having insurance.
Women are increasingly facing the decision between a 2D or 3D mammography; both tests use the same X-ray technology, but 3D tests are more expensive. Kaiser Health News reported that it remains unclear if the 3D test is any better at identifying advanced, lethal cancers. An ongoing 5-year clinical trial will compare the 2 types of mammograms to evaluate if the 3D test reduces the risk that a woman will develop a life-threatening cancer. Currently, the US Preventive Services Task Force recommends biennial mammograms for women between the ages of 50 and 74, but it has not yet recommended 3D mammograms because of a lack of evidence.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More